Literature DB >> 8618482

Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome.

J Reith1, H S Jørgensen, P M Pedersen, H Nakayama, H O Raaschou, L L Jeppesen, T S Olsen.   

Abstract

BACKGROUND: In laboratory animals, cerebral ischaemia is worsened by hyperthermia and improved by hypothermia. Whether these observations apply to human beings with stroke is unknown. We therefore examined the relation between body temperature on admission with acute stroke and various indices of stroke severity and outcome.
METHODS: In a prospective and consecutive study 390 stroke patients were admitted to hospital within 6 h after stroke (median 2.4 h). We determined body temperature on admission, initial stroke severity, infarct size, mortality, and outcome in survivors. Stroke severity was measured on admission, weekly, and at discharge on the Scandinavian Stroke Scale (SSS). Infarct size was determined by computed tomography. Multiple logistic and linear regression outcome analyses included relevant confounders and potential predictors such as age, gender, stroke severity on admission, body temperature, infections, leucocytosis, diabetes, hypertension, atrial fibrillation, ischaemic heart disease, smoking previous stroke, and comorbidity.
FINDINGS: Mortality was lower and outcome better in patients with mild hypothermia on admission; both were worse in patients with hyperthermia. Body temperature was independently related to initial stroke severity (p < 0.009), infarct size (p < 0.0001), mortality (p < 0.02), and outcome in survivors (SSS at discharge) (p < 0.003). For each 1 degrees C increase in body temperature the relative risk of poor outcome (death or SSS score on discharge < 30 points) rose by 2.2 (95% CI 1.4-3.5) (p < 0.002).
INTERPRETATION: We have shown that, in acute human stroke, an association exists between body temperature and initial stroke severity, infarct size, mortality, and outcome. Only intervention trials of hypothermic treatment can prove whether this relation is causal.

Entities:  

Mesh:

Year:  1996        PMID: 8618482     DOI: 10.1016/s0140-6736(96)90008-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  134 in total

Review 1.  Stroke in childhood.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study.

Authors:  P James; C J Ellis; R M Whitlock; A R McNeil; J Henley; N E Anderson
Journal:  BMJ       Date:  2000-06-03

Review 3.  Childhood hemorrhagic stroke: an important but understudied problem.

Authors:  Warren D Lo
Journal:  J Child Neurol       Date:  2011-06-01       Impact factor: 1.987

4.  Acute Ischemic Stroke.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

5.  Intravascular cooling for fever control.

Authors:  Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

6.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 7.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 8.  Treatment or prevention of complications of acute ischemic stroke.

Authors:  L J Kappelle; H B Van Der Worp
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

9.  Body Temperature Modulates Infarction Growth following Endovascular Reperfusion.

Authors:  S Dehkharghani; M Bowen; D C Haussen; T Gleason; A Prater; Q Cai; J Kang; R G Nogueira
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-06       Impact factor: 3.825

10.  A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.

Authors:  J Steven Hata; Constance R Shelsky; Bradley J Hindman; Thomas C Smith; Jonathan S Simmons; Michael M Todd
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.